HRO761 clinical trials

Study of HRO761 Alone or in Combination in Cancer Patients With Specific DNA Alterations Called Microsatellite Instability or Mismatch Repair Deficiency.

This study is testing a new drug, HRO761, for cancers that have specific DNA changes called MSI-high or dMMR. It aims to find a safe and effective dose of HRO761, alone or with other cancer medicines, and see how well it treats these cancers.